Movement DisordersSymptoms, Doctors, Treatments, Advances & More
Learn About Movement Disorders
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Cleveland Clinic Main Campus
Hubert Fernandez is a Neurologist in Cleveland, Ohio. Dr. Fernandez is rated as an Elite provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Movement Disorders, Parkinson's Disease, Tardive Dyskinesia, Deep Brain Stimulation, and Gastric Bypass. Dr. Fernandez is currently accepting new patients.
Emory Brain Health Center
Stewart Factor is a Neurologist in Atlanta, Georgia. Dr. Factor has been practicing medicine for over 44 years and is rated as an Elite provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Parkinson's Disease, Movement Disorders, Tardive Dyskinesia, Deep Brain Stimulation, and Thalamotomy.
Banner Sun Health Research Institute
In my spare time... I enjoy hiking, swimming, and playing fetch with my Sheltie dog. Dr. Shprecher is rated as an Elite provider by MediFind in the treatment of Movement Disorders. His top areas of expertise are Movement Disorders, Parkinson's Disease, Lewy Body Dementia (LBD), and Progressive Supranuclear Palsy.
Summary: The goal of this observational study is to describe the natural history of imprinting disorders (IDs) according to their metabolic profile in all patients (adults and children) affected with an ID regardless of the severity of the disease, with a molecular characterization, with a signed informed consent for all subjects, followed in one partner's center. The main questions it aims to answer are: ...
Summary: This study will examine the long-term safety of buntanetap in participants with PD. This will be a 36-month open-label safety study. This study will be conducted with two cohorts. Cohort 1 will enroll via invitation only for PD participants who have previously participated in buntanetap clinical trials. Cohort 2 will be for PD participants who are receiving deep brain stimulation (DBS) treatment. ...